Detalhe da pesquisa
1.
All is not lost: learning from 9p21 loss in cancer.
Trends Immunol
; 43(5): 379-390, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379580
2.
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.
J Natl Compr Canc Netw
; 22(2D)2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38866043
3.
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.
Br J Cancer
; 128(10): 1888-1896, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859686
4.
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers.
Int J Mol Sci
; 24(2)2023 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36674809
5.
Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents.
Oncologist
; 27(5): 352-362, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285488
6.
Metronomic oral cyclophosphamide in relapsed ovarian cancer.
Int J Gynecol Cancer
; 31(7): 1037-1044, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016703
7.
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.
Breast Cancer Res
; 22(1): 1, 2019 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31892325
8.
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.
Lancet Oncol
; 17(11): 1590-1598, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733243
9.
Three cases of thyroid cancer following the diagnosis of testicular cancer: treatment-related complication or genetics?
Scott Med J
; 61(2): 111-116, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27069005
10.
Targeting T regulatory (Treg) cells in immunotherapy-resistant cancers.
Cancer Drug Resist
; 7: 2, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318526
11.
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma.
Mol Cancer Ther
; 23(3): 394-399, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015561
12.
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).
J Exp Clin Cancer Res
; 43(1): 100, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566164
13.
Promising and Minimally Invasive Biomarkers: Targeting Melanoma.
Cells
; 13(1)2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201222
14.
Remitting Seronegative Symmetrical Synovitis with Pitting Edema: A Case Report of an Immune-Related Adverse Event following Surgery.
Case Rep Oncol
; 16(1): 662-669, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933314
15.
Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy.
Cell Death Dis
; 14(1): 49, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670100
16.
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT).
J Exp Clin Cancer Res
; 42(1): 276, 2023 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865776
17.
Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma.
Mol Cancer Ther
; 21(4): 522-534, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131874
18.
NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer.
Mol Ther Oncolytics
; 16: 289-301, 2020 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32195317
19.
A Case of Lenvatinib-Induced Focal Segmental Glomerulosclerosis (FSGS) in Metastatic Medullary Thyroid Cancer.
Case Rep Oncol Med
; 2018: 6927639, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30402314
20.
A pilot study of subjective well-being in colorectal cancer patients and their caregivers.
Patient Relat Outcome Meas
; 8: 111-119, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29089790